膜聯(lián)蛋白A1(ANXA1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)
ELISA Kit for Annexin A1 (ANXA1)
ANX-A1; ANX1; LPC1; Lipocortin I; Chromobindin-9; Calpactin II; Phospholipase A2 inhibitory protein
- 編號(hào)SEE787Hu
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 實(shí)驗(yàn)方法雙抗夾心
- 反應(yīng)時(shí)長(zhǎng)3h
- 檢測(cè)范圍0.312-20ng/mL
- 靈敏度最小可檢測(cè)劑量小于等于0.118ng/mL.
- 樣本類型serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- 下載 英文說(shuō)明書 中文說(shuō)明書
- 規(guī)格 48T96T 96T*5 96T*10 96T*100
- 價(jià)格 ¥ 2940 ¥ 4200 ¥ 18900 ¥ 35700 ¥ 294000
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
本試劑盒用于檢測(cè)膜聯(lián)蛋白A1(ANXA1),經(jīng)檢測(cè)與其它相似物質(zhì)無(wú)明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來(lái)源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。
回收率
分別于定值血清及血漿樣本中加入一定量的膜聯(lián)蛋白A1(ANXA1)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。
樣本 | 回收率范圍(%) | 平均回收率(%) |
serum(n=5) | 82-101 | 89 |
EDTA plasma(n=5) | 87-99 | 96 |
heparin plasma(n=5) | 91-101 | 97 |
精密度
精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%
線性
在定值血清及血漿樣本內(nèi)加入適量的膜聯(lián)蛋白A1(ANXA1),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中膜聯(lián)蛋白A1(ANXA1)含量的測(cè)定值與理論值的比率。
樣本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 82-89% | 80-92% | 95-105% | 80-101% |
EDTA plasma(n=5) | 79-94% | 85-99% | 80-95% | 78-98% |
heparin plasma(n=5) | 83-102% | 92-101% | 78-96% | 86-95% |
穩(wěn)定性
經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來(lái)進(jìn)行操作可減少人為誤差。
實(shí)驗(yàn)流程
1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本的準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品及樣本)100µL,37°C孵育1小時(shí);
3. 吸棄,加檢測(cè)溶液A100µL,37°C孵育1小時(shí);
4. 洗板3次;
5. 加檢測(cè)溶液B100µL,37°C孵育30分鐘;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分鐘;
8. 加終止液50µL,立即450nm讀數(shù)。
實(shí)驗(yàn)原理
將膜聯(lián)蛋白A1(ANXA1)抗體包被于96孔微孔板中,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本,其中的膜聯(lián)蛋白A1(ANXA1)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的膜聯(lián)蛋白A1(ANXA1)抗體,將未結(jié)合的生物素化抗體洗凈后,加入HRP標(biāo)記的親和素,再次徹底洗滌后加入TMB底物顯色。TMB在過(guò)氧化物酶的催化下轉(zhuǎn)化成藍(lán)色,并在酸的作用下轉(zhuǎn)化成最終的黃色。顏色的深淺和樣品中的膜聯(lián)蛋白A1(ANXA1)呈正相關(guān)。用酶標(biāo)儀在450nm波長(zhǎng)下測(cè)定吸光度(O.D.值),計(jì)算樣品濃度。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APE787Hu01 | 膜聯(lián)蛋白A1(ANXA1)活性蛋白 | Cell?culture;?Activity?Assays. |
RPE787Hu01 | 膜聯(lián)蛋白A1(ANXA1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAE787Hu01 | 膜聯(lián)蛋白A1(ANXA1)多克隆抗體 | WB; IHC; ICC; IP. |
PAE787Hu02 | 膜聯(lián)蛋白A1(ANXA1)多克隆抗體 | WB; IHC; ICC; IP. |
LAE787Hu81 | 膜聯(lián)蛋白A1(ANXA1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
LAE787Hu71 | 膜聯(lián)蛋白A1(ANXA1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAE787Hu22 | 膜聯(lián)蛋白A1(ANXA1)單克隆抗體 | WB |
MAE787Hu21 | 膜聯(lián)蛋白A1(ANXA1)單克隆抗體 | WB; IHC; ICC; IP. |
SEE787Hu | 膜聯(lián)蛋白A1(ANXA1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEE787Hu | 抗膜聯(lián)蛋白A1抗體(Anti-ANXA1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCE787Hu | 膜聯(lián)蛋白A1(ANXA1)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LME787Hu | 膜聯(lián)蛋白A1(ANXA1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSE787Hu01 | 膜聯(lián)蛋白A1(ANXA1)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Plos one | Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease [PubMed: PMC3794972] |
African Journals Online | Modulatory Effect of Phytoestrogens and Curcumin on Induction of Annexin 1 in Human Peripheral Blood Mononuclear Cells and their Inhibitory Effect on Secretory Phospholipase A2 [Ajol: Source] |
Antimicrobial Agents and Chemotherapy | Host Biomarkers of Invasive Pulmonary Aspergillosis to Monitor Therapeutic Response [Asm: Source] |
J Proteomics | Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC) [PubMed: 26718731] |
Diabetes | Annexin A1 Is a Key Modulator of Mesenchymal Stromal Cell–Mediated Improvements in Islet Function [PubMed: 26470781] |
PLoS One | Annexin A1 Is Increased in the Plasma of Preeclamptic Women [PubMed: 26398190] |
中國(guó)現(xiàn)代醫(yī)學(xué)雜志 China Journal of Modern Medicine | 膜聯(lián)蛋白A1 和CA19-9 在膽管癌中的表達(dá)及其臨床意義 [article:8686] |
arteriosclerosis thrombosis and vascular biology | Protective Aptitude of Annexin A1 in Arterial Neointima Formation in Atherosclerosis-Prone Mice-Brief Report. [pubmed:28062503] |
Clinical Science | Mesenchymal stromal cells improve human islet function through released products and extracellular matrix. [pubmed:29101297] |
Biomedicine & Pharmacotherapy | Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity [Pubmed:29677533] |
?International Journal of?Chronic?Obstructive Pulmonary Disease | Annexin A1 is elevated in patients with COPD and affects lung fibroblast function [Pubmed:29440885] |
Medical?Mycology | Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients [Pubmed:29370415] |
DEVELOPMENTAL NEUROPSYCHOLOGY | EFFECTS OF MULTICOMPONENT EXERCISE ON PROGRESSION OF BRAIN ATROPHY AND COGNITION IN AMNESTIC MILD COGNITIVE IMPAIRMENT?… [pdf:3395] |
Multiple sclerosis and related disorders | Resolution of inflammation in neuromyelitis optica spectrum disorders [Pubmed: 30300851] |
Acta Pharmaceutica | Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines [] |
npj Science of Food | Annexin A1 accounts for an anti-inflammatory binding target of sesamin metabolites [Pubmed: 32133417] |
FASEB JOURNAL | ANXA1 directs Schwann cells proliferation and migration to accelerate nerve regeneration through the FPR2/AMPK pathway [Pubmed: 32908567] |
Rev Soc Bras Med Trop | Expression of annexin-A1 in blood and tissue leukocytes of leprosy patients [33263684] |
science advances | Annexin-A1 SUMOylation regulates microglial polarization after cerebral ischemia by modulating IKK|á stability via selective autophagy [33523920] |